Older people and new medicines

International Journal of Pharmaceutical Medicine

Volumn 12, Issue 4, 1998, Pages 207-210

  Crome, P ^a  

^a KEELE UNIVERSITY   (United Kingdom)

Author keywords

Adverse drug reactions; Clinical trials; Drug development; Elderly; Evidence based medicine; Prescribing

Indexed keywords

AGED; DRUG DEVELOPMENT; DRUG EFFICACY; DRUG INDUSTRY; DRUG INFORMATION; EVIDENCE BASED MEDICINE; HUMAN; PRESCRIPTION; PRIORITY JOURNAL; REVIEW;

EID: 0031659473     PISSN: 13649027     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Ageing issue. Br Med J 1997; 315:1029-1104.
2. Kinsella K. Demographic aspects. The epidemiology of ageing. Ebrahim S, Kalache A (editors) London: BMJ Publishing; 1996. pp. 32-40.
3. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991; 337:1521-1526.
4. Griffin JP, Chew R. Trends in usage of prescription medicines by the elderly between 1977 and 1988. London: Association of the British Pharmaceutical Industry; 1990.
5. Manesse CK, Derkx FHM, de Ridder MAJ, in't Veld AJM, van der Cammen TJM. Adverse drug reactions in elderly patients as contributory factor for hospital admission: cross sectional study. Br Med J 1997; 315:1057-1058.
6. Amery A, Birkenhager WH, Brixko P, Bulpitt C, Clement D, Deruyttere M et al. Mortality and morbidity results from the European working party on high blood pressure in the elderly trial. Lancet 1985; I:1349-1354.
7. Rugeja G, Kumar A, Banerjee AK. Exclusion of elderly people from clinical research: a descriptive study of published research. Br Med J 1997; 315:1059.
8. Dawling S, Crome P. Clinical pharmacokinetic considerations in the elderly: an update. Clin Pharmacokinet 1989; 17:236-263.
9. Woodhouse K. Drug handling by the aging liver: past work and future directions. Rev Clin Gerontol 1996; 6:215-223.
10. Kinirons MT, Crome P. Clinical pharmacokinetic considerations in the elderly. Clin Pharmacokinet 1997; 33:302-312.
11. Crome P. The role of elderly volunteer studies in drug development and evaluation [dissertation]. London: University of London; 1994.
12. Crome P, Flanagan RJ. Pharmacokinetic studies in elderly people: are they necessary? Clin Pharmacokinet 1994; 26:243-247.
13. Diener HC, Cunha L, Forbes C et al. A. European stroke prevention study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996; 143:1-13.
14. Rogers SL, Friedhoff LT. The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US multicentre, randomized, double-blind, placebo-controlled trial. The Donepezil Study Group. Dementia 1996; 7:293-303.
15. Cornwall J, Corn TH. Development of pharmacological treatments for Alzheimer-type dementia. J R Soc Med 1994; 87(Suppl 15):19-21.
16. Melzer D. Personal paper: new drug treatment for Alzheimer's disease: lessons for healthcare policy. Br Med J 1998; 316:762-764.